Welcome in CFDB (Cystic Fibrosis DataBase)!
This is a web-based, free access tool for health care professionals, researchers and students to evaluate in real time what are the current evidences about clinical efficacy of interventions in CF.
You'll find more than 1,300 studies divided in 8 sections, including Cochrane reviews, Cochrane protocols, DARE, HTA and Economic reviews, published RCT, published non-RCT, congress abstracts and ongoing trials.
Objective of CFDB (Cystic Fibrosis DataBase)
CFDB is a database and was ideated to classify clinical studies to get answers to specific questions:
- which interventions are effective, in which groups of CF patients and for which outcomes?
- to what extent do the results of the literature allow to make decisions for specific clinical issues? What issues need to be studied further?
This tool may help clinicians, researchers, students to have a faster updated view of clinical research in CF by using queries on the main topics in CF care. It could also be helpful to anyone going to design new studies, as it provides a concise description of what is currently known and what issues, on the contrast, need additional research.
Latest articles
Appetite stimulants for people with cystic fibrosis
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2022
- McTavish D
Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2022
- Francis NZ
Dietary interventions for managing glucose abnormalities in people with cystic fibrosis
Cochrane Database of Systematic Reviews - Cochrane Protocol (ongoing review)
Details- 2022
- Birch L
Gut Bifidobacteria enrichment following oral Lactobacillus-supplementation is associated with clinical improvements in children with cystic fibrosis.
primary studies published RCT
Details- 2022
- Ray KJ
Impact of pharmacy services on time to elexacaftor-tezacaftor-ivacaftor initiation.
primary studies published, non RCT
Details- 2022
- Roder L
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study - Phase 4 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- Chris Goss|University of Washington|Medical University of South Carolina|Cystic Fibrosis Foundation|Seattle Children's Hospital
A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa - Phase 1|Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2022
- National Institute of Allergy and Infectious Diseases (NIAID)